Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 246 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TICAGRELOR | 90MG | TABLET | Resolved | 2024-01-19 | 2024-03-29 | 216675 |
APO-BROMFENAC | 0.07% | SOLUTION | Resolved | 2024-01-19 | 2024-03-22 | 216678 |
APO-AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-01-19 | 2024-02-23 | 216681 |
APO-METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-02-23 | 217300 |
APO-TRYPTOPHAN | 500MG | TABLET | Resolved | 2024-01-26 | 2024-04-05 | 217469 |
APO-MIDODRINE | 5MG | TABLET | Resolved | 2024-01-26 | 2024-05-24 | 217472 |
ZAMINE 28 | 0.03MG 3MG | TABLET | Resolved | 2024-01-26 | 2024-03-08 | 217475 |
APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-01-26 | 2024-02-16 | 217478 |
APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-05-31 | 217481 |
APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-01-26 | 2024-03-15 | 217487 |
APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2024-01-26 | 2024-03-01 | 217490 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2024-02-02 | 2024-03-15 | 218370 |
APO-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-02-02 | 2024-03-22 | 218373 |
APO-METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-02-02 | 2024-02-23 | 218376 |
APO-CINACALCET | 60MG | TABLET | Resolved | 2024-02-02 | 2024-03-22 | 218382 |
APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2024-02-02 | 2024-03-08 | 218385 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2024-02-02 | 2024-03-01 | 218388 |
ZAMINE 21 | 0.03MG 3MG | TABLET | Resolved | 2024-02-02 | 2024-03-29 | 218391 |
APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2024-02-02 | 2024-04-19 | 218394 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2024-02-02 | 2024-04-12 | 218397 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-07-12 | 2019-07-13 | 89135 |
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-08-07 | 2019-08-07 | 91117 |
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
APO-CLINDAMYCIN | 150MG | CAPSULE | Discontinued | 2019-11-11 | 2019-11-11 | 98363 |
APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
APO-DIPYRIDAMOLE | 25MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101888 |
APO-DIPYRIDAMOLE | 50MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101891 |
APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |
APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |